Endoscopic Submucosal Dissection (ESD)

What is ESD (Endoscopic Submucosal Dissection)?

Endoscopic Submucosal Dissection (ESD) is an advanced endoscopic surgical modality utilized to resect early-stage malignancies or large neoplasms within the gastrointestinal tract (esophagus, stomach, and colon). It allows for the direct intraluminal dissection and removal of diseased tissue, eliminating the need for invasive surgical organ resection.

How is ESD Performed?

ESD is a technically demanding procedure that operates on a precise “dissection” principle through several sequential stages:

• Marking: The lateral margins of the lesion are carefully inspected, and electrocautery dots are placed around its periphery to define the resection boundaries.
• Lifting (Submucosal Injection): A specialized solution is injected into the submucosal layer directly beneath the lesion. This elevates the diseased mucosa, separating it from the underlying deep muscularis propria layer to create a safe working cushion.
• Circumferential Incision: Utilizing specialized endoscopic micro-knives passed through the endoscope, a complete 360-degree incision is made through the mucosa around the marked boundaries of the lesion.
• Submucosal Dissection: The operator dissects the connective tissue fibers within the submucosal layer millimeter by millimeter, completely freeing the neoplastic lesion from the underlying healthy muscular wall.
• En-Bloc Retrieval: Regardless of its size, the tumor is resected and retrieved intact as a single, undivided specimen (en-bloc resection).

Why is ESD Preferred? (Clinical Superiority)

The primary distinction and advantage of ESD over other modalities—such as Endoscopic Mucosal Resection (EMR)—lies in its ability to avoid tissue fragmentation:

• Definitive Histopathological Analysis: Because the specimen is retrieved en-bloc, the pathologist can accurately evaluate the lateral and vertical resection margins to definitively confirm whether complete ($R0$) curative resection was achieved.
• Organ Preservation: Neoplasms that historically required major surgical resection of a significant portion of the stomach or colon can now be treated by precisely dissecting only the diseased mucosal layer from within, leaving the organ fully intact.
• Reduced Local Recurrence Rates: Because the tissue is resected with deeper and wider margins, the risk of local disease recurrence at the intervention site is significantly lower compared to other endoscopic techniques.

Patient Selection: Who is Eligible for ESD?

• Early-stage gastric, esophageal, and colorectal carcinomas that have not invaded the deep muscularis propria layer.
• Broad, flat, or sessile lesions larger than 2 cm that cannot be safely or completely resected en-bloc using standard snare techniques (EMR).
• Recurrent or fibrotic lesions remaining from previous incomplete interventions.

Post-Procedural Clinical Advantages

ESD delivers the therapeutic efficacy of oncological surgery combined with the minimally invasive comfort of endoscopy:

• No External Incisions: The procedure leaves no abdominal scars or external wounds.
• Rapid Recovery: Patients are typically monitored in the hospital for only 1 to 2 days before returning to their regular daily routines.
• Preserved Digestive Function: Since the baseline volume and anatomy of the stomach or colon are unaltered, patients do not suffer from the severe post-operative nutritional and dietary challenges associated with anatomical surgical resections.

Ultimately, ESD is a powerful technology that achieves the outcome of an open surgical scalpel entirely through the working channel of an endoscope. It represents the clinical pinnacle where early detection translates directly into definitive, organ-preserving cure.